Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 32% ± 10% | |
macrophage | 6 studies | 21% ± 6% | |
endothelial cell | 5 studies | 22% ± 6% | |
astrocyte | 4 studies | 19% ± 3% | |
lymphocyte | 3 studies | 18% ± 1% | |
GABAergic neuron | 3 studies | 37% ± 9% | |
glutamatergic neuron | 3 studies | 42% ± 12% | |
basal cell | 3 studies | 25% ± 6% | |
goblet cell | 3 studies | 29% ± 12% | |
transit amplifying cell | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4311.70 | 1445 / 1445 | 100% | 24.35 | 183 / 183 |
intestine | 100% | 4796.99 | 966 / 966 | 100% | 28.05 | 527 / 527 |
ovary | 100% | 4697.52 | 180 / 180 | 100% | 25.32 | 430 / 430 |
pancreas | 100% | 2953.05 | 328 / 328 | 100% | 22.57 | 178 / 178 |
stomach | 100% | 3883.46 | 359 / 359 | 100% | 24.07 | 286 / 286 |
uterus | 100% | 4757.48 | 170 / 170 | 100% | 25.35 | 459 / 459 |
thymus | 100% | 6270.45 | 653 / 653 | 100% | 27.56 | 604 / 605 |
lung | 100% | 4162.96 | 577 / 578 | 100% | 21.11 | 1155 / 1155 |
breast | 100% | 4147.69 | 459 / 459 | 100% | 21.79 | 1116 / 1118 |
prostate | 100% | 5122.36 | 245 / 245 | 100% | 25.11 | 501 / 502 |
skin | 100% | 4762.80 | 1809 / 1809 | 100% | 27.88 | 471 / 472 |
kidney | 100% | 5858.01 | 89 / 89 | 100% | 22.15 | 899 / 901 |
bladder | 100% | 4126.05 | 21 / 21 | 100% | 25.26 | 502 / 504 |
adrenal gland | 100% | 5897.29 | 258 / 258 | 100% | 21.70 | 229 / 230 |
brain | 99% | 3303.20 | 2617 / 2642 | 100% | 21.13 | 705 / 705 |
liver | 100% | 2556.58 | 226 / 226 | 98% | 13.26 | 398 / 406 |
adipose | 100% | 3662.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 27.56 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.47 | 29 / 29 |
spleen | 100% | 6563.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.30 | 1 / 1 |
blood vessel | 100% | 3900.33 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2450.58 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3042.00 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5348.75 | 919 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043249 | Biological process | erythrocyte maturation |
GO_0051301 | Biological process | cell division |
GO_0007155 | Biological process | cell adhesion |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0033033 | Biological process | negative regulation of myeloid cell apoptotic process |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0048822 | Biological process | enucleate erythrocyte development |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005826 | Cellular component | actomyosin contractile ring |
GO_0034657 | Cellular component | GID complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0003779 | Molecular function | actin binding |
Gene name | MAEA |
Protein name | Macrophage erythroblast attacher, E3 ubiquitin ligase E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Macrophage erythroblast attacher) E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein) (HLC-10) (Macrophage erythroblast attacher) (P44EMLP) E3 ubiquitin-protein transferase MAEA (Macrophage erythroblast attacher) Macrophage erythroblast attacher, isoform CRA_c (cDNA FLJ34632 fis, clone KIDNE2015660, highly similar to Homo sapiens macrophage erythroblast attacher (MAEA), transcript variant 2, mRNA) |
Synonyms | PIG5 hCG_1646851 EMP HLC10 |
Description | FUNCTION: Core component of the CTLH E3 ubiquitin-protein ligase complex that selectively accepts ubiquitin from UBE2H and mediates ubiquitination and subsequent proteasomal degradation of the transcription factor HBP1. MAEA and RMND5A are both required for catalytic activity of the CTLH E3 ubiquitin-protein ligase complex . MAEA is required for normal cell proliferation . The CTLH E3 ubiquitin-protein ligase complex is not required for the degradation of enzymes involved in gluconeogenesis, such as FBP1 . Plays a role in erythroblast enucleation during erythrocyte maturation and in the development of mature macrophages (By similarity). Mediates the attachment of erythroid cell to mature macrophages; this MAEA-mediated contact inhibits erythroid cell apoptosis . Participates in erythroblastic island formation, which is the functional unit of definitive erythropoiesis. Associates with F-actin to regulate actin distribution in erythroblasts and macrophages (By similarity). May contribute to nuclear architecture and cells division events (Probable). . |
Accessions | D6R8Z3 ENST00000512842.5 E7ESC7 ENST00000510794.5 D6RIB6 ENST00000513301.5 ENST00000514708.5 ENST00000509254.5 ENST00000503653.5 ENST00000505839.1 ENST00000505177.6 ENST00000502558.5 D6RE80 B4DQT1 B4DVN3 D6RDW4 D6REW7 Q7L5Y9 ENST00000303400.9 [Q7L5Y9-1] B3KRN7 D6RID6 ENST00000264750.10 [Q7L5Y9-3] ENST00000509531.5 D6RA86 ENST00000512308.5 |